ORBIMED ADVISORS LLC - 31 Dec 2024 SCHEDULE 13G Report for Forte Biosciences, Inc. Common Stock, par value $0.001 per share (FBRX)

Filing Manager: ORBIMED ADVISORS LLC
Reporting Manager: ORBIMED ADVISORS LLC
Security: Forte Biosciences, Inc. Common Stock, par value $0.001 per share
Symbol: FBRX
Shares outstanding: 6,375,000 shares
Disclosed Ownership: 510,000 shares
Ownership: 8%
Form type: SCHEDULE 13G
Filing time: 14 Feb 2025, 16:22:11 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
ORBIMED ADVISORS LLC	8%	510,000	0	510,000	/s/ Carl L. Gordon	Carl L. Gordon/Member
ORBIMED CAPITAL LLC	1.4%	90,000	90,000	0	/s/ Carl L. Gordon	Carl L. Gordon/Member